Document is current
Any future updates will be listed below
-
Authors
Chen, Jingnan
Dong, Yidan
Zhao, Jiajun
Lai, Yuwei
Xiao, Congmei
Fu, Yuanqing
Zhang, Ke
Ye, Meng
Gou, Wanglong
Hu, Shijia
Miao, Zelei
Li, Fan
Wu, Ping
Wang, Tianlei
Yuan, Jiaying
Hu, Yayi
Wu, Jin
Pan, An
Pan, Xiong-Fei
Zheng, Ju-Sheng
-
Funding
Funding for this research was provided by:
Sichuan Provincial Science and Technology Support Program (2023ZYD0120)
National Key Research and Development Program of China (2024YFC2707602)
National Key Research and Development Program of China (2022YFA1303900)
National Natural Science Foundation of China (82473646)
National Natural Science Foundation of China (92374112)
Sichuan Provincial Natural Science Foundation (2024NSFSC0578)
Fundamental Research Funds for the Central Universities (YJ202346)
Key Scientific Research Program Project of Hangzhou (2025SZD1B08)
Zhejiang Provincial Key Laboratory Construction Project (2024ZY01026)
Platform Development for Novel Vaccines and Antibodies (2024E10060)
- License Information
-
More Information
Article History
Received: 8 August 2025
Accepted: 11 February 2026
First Online: 18 February 2026
Declarations
:
: The THSBC study was approved by the Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology (Number: [2017]-(S225)-1). The WeBirth was approved by the Ethics Committee of Westlake University (approval numbers: 20190701ZJS0007). Written informed consent was obtained for all participants.
: Not applicable.
: The authors declare no competing interests.
